Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) (Descending) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00781-3136-70 00781-3136 Methylprednisolone Acetate Methylprednisolone Acetate 40.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-articular, Intralesional, Intramuscular, Soft Tissue Jan. 29, 2009 Oct. 31, 2014 In Use
00781-3132-95 00781-3132 Methylprednisolone Acetate Methylprednisolone Acetate 80.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-articular, Intralesional, Intramuscular, Parenteral, Soft Tissue March 5, 2009 May 31, 2014 In Use
00781-3132-71 00781-3132 Methylprednisolone Acetate Methylprednisolone Acetate 80.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-articular, Intralesional, Intramuscular, Parenteral, Soft Tissue March 5, 2009 May 31, 2014 In Use
00781-3131-95 00781-3131 Methylprednisolone Acetate Methylprednisolone Acetate 40.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-articular, Intralesional, Intramuscular, Parenteral, Soft Tissue March 5, 2009 May 31, 2014 In Use
00781-3131-71 00781-3131 Methylprednisolone Acetate Methylprednisolone Acetate 40.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-articular, Intralesional, Intramuscular, Parenteral, Soft Tissue March 5, 2009 May 31, 2014 In Use
00781-3084-75 00781-3084 Triamcinolone Hexacetonide Aristospan 5.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intralesional, Parenteral July 29, 1969 May 31, 2016 In Use
00781-3079-12 00781-3079 Fulvestrant Fulvestrant 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular May 29, 2019 Sept. 30, 2024 In Use
00781-3031-75 00781-3031 Estradiol Valerate Estradiol Valerate Hormonal Therapy Estrogen Oct. 4, 2007 Aug. 31, 2011 No Longer Used
00781-3030-75 00781-3030 Estradiol Valerate Estradiol Valerate Hormonal Therapy Estrogen Oct. 4, 2007 Jan. 31, 2010 No Longer Used
00781-3029-75 00781-3029 Estradiol Valerate Estradiol Valerate Hormonal Therapy Estrogen Oct. 4, 2007 Dec. 31, 2011 No Longer Used
00781-3011-80 00781-3011 Ondansetron Ondansetron Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous July 27, 2007 Oct. 31, 2011 No Longer Used
00781-3010-95 00781-3010 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous June 27, 2007 March 31, 2017 No Longer Used
00781-3010-72 00781-3010 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous June 27, 2007 March 31, 2017 No Longer Used
00781-2696-75 00781-2696 Temozolomide Temozolomide 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2695-75 00781-2695 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2695-44 00781-2695 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2694-75 00781-2694 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2694-44 00781-2694 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2693-75 00781-2693 Temozolomide Temozolomide 100.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2693-44 00781-2693 Temozolomide Temozolomide 100.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2692-75 00781-2692 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2692-44 00781-2692 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2691-75 00781-2691 Temozolomide Temozolomide 5.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2691-44 00781-2691 Temozolomide Temozolomide 5.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug. 12, 2013 In Use
00781-2323-68 00781-2323 Aprepitant Aprepitant 125.0 mg/1 Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Oral Dec. 27, 2016 In Use

Found 10,000 results in 10 milliseconds — Export these results